Nigeria: Researchers Move to Unveil Complete Protection Against Malaria
[Guardian] Ahead of the World Malaria Day (WMD) holding next Thursday, researchers are to begin the first large field trial in West Africa of a malaria vaccine that offers complete protection against the disease. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 18, 2019 Category: Infectious Diseases Source Type: news

Malawi: Malawi Piloting the World's First Malaria Vaccine
[Nyasa Times] Malawi government says a vaccine against malaria could be a vital new tool in the fight against the debilitating illness as the Ministry of Health starts immunising children in the world's first large-scale pilot of RTS, S -- the candidate vaccine that is furthest along in development --from April 23 2019. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 18, 2019 Category: African Health Source Type: news

US and Malawian partners implement malaria vaccine for children in Africa
(University of North Carolina Health Care) The world's first vaccine for malaria will be tested in a pilot study beginning this April in three countries with a high burden of the disease among children, according to researchers leading the project from the UNC School of Medicine and UNC Project-Malawi. In Malawi, malaria is the main cause of illness and death among children age five and younger. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 17, 2019 Category: Infectious Diseases Source Type: news

Ghana: Ghana Starts Malaria Vaccine Implementation
[Ghana Govt.] Ghana has started phase one of malaria vaccine implementation in selected districts across the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 12, 2019 Category: African Health Source Type: news

Ghana: Ghana Announces the Roll Out of Malaria Vaccine Implementation Programme (Mvip)
[WHO] Ghana has announced the roll out of the Malaria Implementation Programme in a press briefing held on 10th April 2019 in Accra. The event was attended by the WHO Country Representative Dr Owen Kaluwa and other officers from the Country Office, The Director General of the Ghana Health Service Dr Anthony Nsiah- Asare, officials from the Expanded Programme for Immunization (EPI) Programme representatives of MVIP Evaluation Partners, Officials from Foods and Drugs Authority (FDA), Coalition of NGOs in Health, r (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 11, 2019 Category: African Health Source Type: news

Malawi: Government to Roll Out Malaria Vaccine This Month
[Malawi News Agency] Balaka -pic by Mary Makhiringa (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 8, 2019 Category: African Health Source Type: news

Global Health: Cholera Is Spreading in Mozambique, and It ’ s Far From the Only Health Threat
About two million people are displaced, cholera has broken out, and malaria is expected. But doses of cholera vaccine have arrived, and the humanitarian crisis may yet be contained, aid agencies say. (Source: NYT Health)
Source: NYT Health - April 3, 2019 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Cholera Epidemics Humanitarian Aid Vaccination and Immunization Cyclones Malaria World Health Organization Doctors Without Borders International Committee of the Red Cross Oxfam Mozambique Africa Source Type: news

Malawi: Malaria Vaccine Programme for Under-5 Children Launched in Mangochi
[Nyasa Times] Children under five years will this month start receiving malaria vaccine in Mangochi under the pilot Malaria Vaccine Implementation Programme (MVIP) by the district health office and College of Medicine. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 2, 2019 Category: Infectious Diseases Source Type: news

Mayo Clinic Q and A: Malaria continues to be a significant travel-related disease
DEAR MAYO CLINIC:?I'm planning a three-week trip to Tanzania. My doctor recommends that I take medication to prevent malaria. Is this really necessary? I thought malaria wasn't common anymore. Are there other things that I can do to protect myself? Is effective treatment available for malaria? ?ANSWER:?While there is no vaccine for malaria, it is [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 15, 2019 Category: Databases & Libraries Source Type: news

Computer-designed vaccine elicits potent antibodies against RSV
A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus (RSV) has been designed in an international research effort. RSV is second only to malaria as a cause of infant mortality worldwide. The new vaccine elicits potent neutralizing antibodies against RSV in both mice and monkeys. The animal research findings, reported March 7 in the journal Cell, pave the way for human clinical trials. (Source: World Pharma News)
Source: World Pharma News - March 8, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Computer-Designed Vaccine Elicits Potent Antibodies
A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus (RSV) has been designed in an international research effort. RSV is second only to malaria as a cause of infant mortality worldwide. The new vaccine elicits potent neutralizing antibodies against RSV in both mice and monkeys. The animal research findings, reported March 7 in the journal Cell, pave the way for human clinical trials. (Source: eHealth News EU)
Source: eHealth News EU - March 8, 2019 Category: Information Technology Tags: Featured Research Research and Development Source Type: news

Nobi, 42 – Testimony of Rohingya
As I walked with him through the camp, we could hear the residents call: “Nobi vai!” (Brother Nobi!). Nobi is undoubtedly very popular in the area. As a leader among Doctors of the World’s volunteers, he is also a major pillar in community work. Nevertheless, his gestures and words are humble, smart, and calm. He discusses quietly about the need for a clinic for the inhabitants, but then he wells up as he starts to talk about his 2-year-old son. Being a father, a community leader, and a community worker is a heavy burden. His warm human nature feels like a healing energy for the inhabitants of the camp wh...
Source: Doctors of the World News - February 22, 2019 Category: International Medicine & Public Health Authors: Martina Villa Tags: Uncategorised Source Type: news

Patients often avoid vaccinations due to fear of side effects
Social media may fuel misconceptions over vaccinations Related items fromOnMedica Double check patients with ‘penicillin’ allergy to avoid MRSA risk Malaria cases rise sharply Africans in the UK most likely to acquire malaria A fifth of unvaccinated ethnic girls say they don ’t need HPV jab NICE urges wider uptake of flu vaccination (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 24, 2019 Category: UK Health Source Type: news

New OHSU vaccine shows promise against malaria
The vaccine was still stimulating an immune response in infected monkeys a year after it was administered. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 23, 2019 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

New OHSU vaccine shows promise against malaria
The vaccine was still stimulating an immune response in infected monkeys a year after it was administered. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 23, 2019 Category: American Health Authors: Elizabeth Hayes Source Type: news

New vaccine offers fresh take on malaria fight
(Oregon Health& Science University) Early research on a new approach to protecting against malaria is offering promising, potentially long-lasting results against the persistent parasite that sickens hundreds of millions people each year. The approach uses a cytomegalovirus-based platform that's already being used in vaccines being developed to battle HIV and tuberculosis. This new vaccine reduced the malaria-causing parasite's release from the liver and into the blood of infected rhesus macaques by 75 to 80 percent, reports a paper published in the journal PLOS ONE. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 23, 2019 Category: Biology Source Type: news

Superbugs, Anti-Vaxxers Make WHO ’ s List Of 10 Global Health Threats
(CNN) — From climate change to superbugs, the World Health Organization has laid out 10 big threats to our global health in 2019. And unless these threats get addressed, millions of lives will be in jeopardy. Here’s a snapshot of 10 urgent health issues, according to the United Nations’ public health agency: Not vaccinating when you can One of the most controversial recent health topics in the US is now an international concern. “Vaccine hesitancy — the reluctance or refusal to vaccinate despite the availability of vaccines — threatens to reverse progress made in tackling vaccine-prevent...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 21, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Local TV Source Type: news

Danish malaria vaccine passes test in humans
For many years, a team of researchers at the University of Copenhagen have been focussing on developing a vaccine that can protect against the disease pregnancy malaria from which 220,000 people die every year. Now they have come a significant step closer to being able to introduce such a vaccine in the market. In a new study published in the scientific journal Clinical Infectious Diseases the vaccine has been subjected to so-called phase one clinical trial, and the results are uplifting: (Source: World Pharma News)
Source: World Pharma News - January 11, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Danish malaria vaccine passes test in humans
(University of Copenhagen The Faculty of Health and Medical Sciences) A vaccine against fatal pregnancy malaria shows promising results in the first tests in humans. The new study conducted at the University of Copenhagen has untraditionally taken a vaccine all the way from discovery of a mechanism through development and production to clinical trials in humans. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 10, 2019 Category: Infectious Diseases Source Type: news

Toward a chemical vaccine for malaria
(Source: ScienceNOW)
Source: ScienceNOW - December 6, 2018 Category: Science Authors: Phillips, M. A., Goldberg, D. E. Tags: perspective Source Type: news

Africa: Novel Approach Brings African Scientists Closer to a Malaria Vaccine
[The Conversation Africa] Malaria is still a major problem in Africa. There are over 200 million clinical cases each year and approximately half a million deaths. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - November 14, 2018 Category: Infectious Diseases Source Type: news

Cardiac experts urge patients to get flu vaccine
Vaccine can cut risk of heart and circulatory deaths by 24% Related items fromOnMedica HIV therapy helps protect men from Hep B infection Malaria cases rise sharply BMJ report questions swine flu jab transparency NICE urges wider uptake of flu vaccination Boys will receive HPV vaccine (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 2, 2018 Category: UK Health Source Type: news

A study identifies new markers associated with protection by the RTS,S malaria vaccine
(Barcelona Institute for Global Health (ISGlobal)) Protection conferred by the RTS,S malaria vaccine depends greatly on the amount and subclass of antibodies generated upon vaccination, and on previous exposure levels to the parasite, according to a study led by ISGlobal, an institution supported by 'la Caixa' Foundation. The results, published in BMC Medicine, shed new light on the mechanisms by which RTS,S confers protection and provide the basis for developing more efficacious vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 30, 2018 Category: Infectious Diseases Source Type: news

Q & A on the investigational vaccine candidate M72/AS01E
M72/AS01E is a subunit vaccine comprised of an immunogenic fusion protein (M72) derived from two Mycobacterium tuberculosis (M.tb) antigens (MTB32A and MTB39A), and the GlaxoSmithKline (GSK) proprietary adjuvant AS01E. AS01E is the same adjuvant used in Shingrix GSK vaccine, as well as in the new malaria vaccine RTS,S/AS01E. The M72/AS01E vaccine candidate is being developed by the pharmaceutical company GlaxoSmithKline, in partnership with AERAS. AERAS is a not for profit organization based in the US, aimed at supporting tuberculosis vaccine research, funded by the Bill and Melinda Gates foundation, the UK Department for ...
Source: WHO Feature Stories - October 10, 2018 Category: International Medicine & Public Health Tags: tuberculosis [subject], tb Source Type: news

Vaccinating humans to protect mosquitoes from malaria
(University at Buffalo) For decades, scientists have been trying to develop a vaccine that prevents mosquitoes from spreading malaria among humans. This unique approach -- in which immunized humans transfer anti-malarial proteins to mosquitoes when bitten -- is called a transmission-blocking vaccine (TBV). A new biotech advancement moves us closer to this goal. If successful, it could help reduce the spread of the disease, which kills more than 400,000 people annually. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 8, 2018 Category: Infectious Diseases Source Type: news

Bill Gates Talks to TIME About a Coming ‘Third Wave’ of Development in Africa
There’s a very big difference between simple and easy—especially when it comes to global health. It’s simple to eradicate polio—just get all children are vaccinated. It’s simple to reduce nighttime malaria infections—make sure everyone in malaria-endemic areas sleeps under a bed net. But none of that is easy. The tension between simple and easy is at play when it comes to eradicating poverty in the developing world too, as the Bill & Melinda Gates Foundation makes clear in its second annual Goalkeepers Data Report. In a conversation with TIME, Bill Gates points to two recent waves of...
Source: TIME: Health - September 21, 2018 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized onetime public health Source Type: news

Malaria treatment: Is there a vaccine for Malaria?
MALARIA is currently plaguing the Indonesian tourist island of Lombok, where a recent earthquake devastated the country, paving the way for a potentially deadly Malaria outbreak. Is there a vaccine for Malaria? (Source: Daily Express - Health)
Source: Daily Express - Health - September 19, 2018 Category: Consumer Health News Source Type: news

Global Health: Vaccines Against H.I.V., Malaria and Tuberculosis Unlikely, Study Says
Unless the $3 billion spent annually on research triples, the world may not be able to invent vaccines or rapid cures for many ills of the poor. (Source: NYT Health)
Source: NYT Health - September 7, 2018 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Vaccination and Immunization Tests (Medical) Tuberculosis Acquired Immune Deficiency Syndrome Malaria Third World and Developing Countries Duke University Gates, Bill and Melinda, Foundation Fauci, Anthony S Source Type: news

Effective TB, HIV, malaria vaccines missing from pipeline
(Duke University) Many of the vaccines critically needed to fight the world's most prevalent infectious diseases are not likely to be developed. A financial modeling study of 538 candidate products for 35 neglected diseases estimated the costs and likelihood that each would progress to a product launch. Using a new tool known as Portfolio-to-Impact (P2I), the researchers found only 128 of those candidates would make it through the drug development pipeline. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 4, 2018 Category: International Medicine & Public Health Source Type: news

Health systems in low- and middle-income countries not prepared to diagnose and treat common diseases
Cardiovascular diseases, chronic respiratory diseases and diabetes are among the leading causes of death worldwide. A new UCLA study has found that Bangladesh, Haiti, Malawi, Nepal and Tanzania each has fewer than five health facilities that can provide the full suite of supplies and equipment, trained staff and medication that are needed to properly diagnose and treat all three diseases.“These five countries, paralleling global trends, are seeing an increase in the number of people with these noncommunicable diseases,” said the lead author, Corrina Moucheraud, assistant professor of health policy and managemen...
Source: UCLA Newsroom: Health Sciences - August 6, 2018 Category: Universities & Medical Training Source Type: news

Yale researchers identify target for novel malaria vaccine
Researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 13, 2018 Category: Universities & Medical Training Source Type: news

Yale researchers identify target for novel malaria vaccine
(Yale University) A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites use to evade the immune system. The study was published by Nature Communications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2018 Category: International Medicine & Public Health Source Type: news

Certain antibodies against a sugar are associated with malaria protection
(Barcelona Institute for Global Health (ISGlobal)) Certain type of antibodies againstα-Gal- a carbohydrate expressed by many organisms including the malaria parasite- could protect against malaria, according to a new study led by ISGlobal, an institution supported by 'la Caixa' Foundation. The results, published in Scientific Reports, indicate that a-Gal is an interesting candidate to include in future vaccines against malaria and other infectious diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2018 Category: International Medicine & Public Health Source Type: news

Research suggests new vaccine candidates for malaria
(American Society for Microbiology) Researchers have shown that higher levels of Plasmodium falciparum antibodies are protective against severe malaria in children living in Papua New Guinea. Children who have higher levels of antibodies to a specific short amino acid sequence in the malaria parasite, P. falciparum, have much lower rates of clinical and severe malaria. This amino acid sequence, an antigen, is similar among P. falciparum strains elsewhere in the world, suggesting that this antigen would make a good target for a malaria vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 6, 2018 Category: International Medicine & Public Health Source Type: news

New & Resurgent Infectious Diseases Can Have Far-reaching Economic Repercussions
DAVID E. BLOOM is the Clarence James Gamble Professor of Economics and Demography, DANIEL CADARETTE is a research assistant, and JP SEVILLA is a research associate, all at Harvard University’s T.H. Chan School of Public Health.By David E. Bloom, Daniel Cadarette and JP SevillaWASHINGTON DC, Jul 3 2018 (IPS)Infectious diseases and associated mortality have abated, but they remain a significant threat throughout the world.We continue to fight both old pathogens, such as the plague, that have troubled humanity for millennia and new pathogens, such as human immunodeficiency virus (HIV), that have mutated or spilled over ...
Source: IPS Inter Press Service - Health - July 3, 2018 Category: International Medicine & Public Health Authors: David E. Bloom and JP Sevilla Tags: Active Citizens Development & Aid Economy & Trade Global Headlines Health TerraViva United Nations Source Type: news

A promising new tool to measure antibodies against malaria
(Barcelona Institute for Global Health (ISGlobal)) Antibodies against multiple Plasmodium falciparum proteins (or antigens) can be measured using a simple, accurate and reproducible assay that requires very small amounts of blood. In a series of recently published articles, a team led by ISGlobal -- an institution supported by 'la Caixa' Foundation -- reports the development and optimisation of several 'quantitative suspension array' assays (qSAT) that could help assess natural and vaccine-induced responses to malaria and other parasites. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 3, 2018 Category: Infectious Diseases Source Type: news

How a Drug For Pets May Help Prevent Zika and Malaria
Diseases spread by pests like mosquitoes and fleas remain global health problems. To prevent transmission, public health strategy has largely focused on using insecticides or bed nets. Vaccines are also under development for diseases like Zika, but few are approved for use. Now, a new study suggests that medicines already used for pets to protect against fleas and ticks could offer similar protection for humans. In the report, published Monday in the journal Proceedings of the National Academy of Sciences, researchers at the nonprofit drug discovery institute Calibr and TropIQ Health Sciences report that drugs called isoxa...
Source: TIME: Health - July 2, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized healthytime Innovation Health public health Source Type: news

How a Drug For Pets May Help Prevent Zika and Malaria
Diseases spread by pests like mosquitoes and fleas remain global health problems. To prevent transmission, public health strategy has largely focused on using insecticides or bed nets. Vaccines are also under development for diseases like Zika, but few are approved for use. Now, a new study suggests that medicines already used for pets to protect against fleas and ticks could offer similar protection for humans. In the report, published Monday in the journal Proceedings of the National Academy of Sciences, researchers at the nonprofit drug discovery institute Calibr and TropIQ Health Sciences report that drugs called isoxa...
Source: TIME: Science - July 2, 2018 Category: Science Authors: Alexandra Sifferlin Tags: Uncategorized healthytime Innovation Health public health Source Type: news

Nigeria:Could a New Typhoid Vaccine End the Most Misdiagnosed Disease in Nigeria?
[Nigeria Health Watch] "Typhoid fever" has long been recognized as one of the most diagnosed diseases in Nigeria. The challenge is that when diagnosed properly, typhoid fever is actually a life-threatening infection caused by the bacterium Salmonella Typhi. It is usually spread through contaminated food or water, and symptoms, including prolonged fever, fatigue, headache, nausea, and abdominal pain are very similar to those of the most common cause of fever in Nigeria -- malaria. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 28, 2018 Category: African Health Source Type: news

First malaria-human contact mapped with Nobel Prize-winning technology
(Walter and Eliza Hall Institute) Melbourne scientists have taken a significant step toward developing a new vaccine for malaria, revealing for the first time an 'atomic-scale' blueprint of how the parasite invades human cells.Using the Nobel Prize-winning technology cryo-EM (cryo-electron microscopy), the researchers mapped the previously hidden first contact between Plasmodium vivax malaria parasites and young red blood cells they invade to begin the parasites' spread throughout the body. The discovery was published today in Nature. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 27, 2018 Category: Infectious Diseases Source Type: news

Killer immune cells that halt malaria could hold key to new vaccines
(eLife) Scientists have revealed that immune cells called natural killer (NK) cells may play a key role in ridding the body of malaria-infected blood cells, a study in eLife reports. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 26, 2018 Category: Infectious Diseases Source Type: news

Combining different malaria vaccines could reduce cases by 91 percent
Using two experimental anti-malarial vaccines can greatly reduce the number of malaria infections in animal studies, according to a research team that includes MRC scientists. (Source: Medical Research Council General News)
Source: Medical Research Council General News - June 20, 2018 Category: Research Source Type: news

Combining different malaria vaccines could reduce cases by 91 percent
(Imperial College London) Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news

How Community Health Workers Could Save 30 Million Lives By 2030
When Dr. Raj Panjabi talks about starting his nonprofit, Last Mile Health, he describes being motivated by both love and outrage. At nine years old, Panjabi had to flee his home in Liberia to escape civil war; he and his family relocated to the U.S. When Panjabi returned to his home country as a medical student, he discovered there were only 51 doctors left to serve the country’s four million people. As a result, many residents were dying from treatable conditions, especially in rural areas, simply because they lived too far away from doctors and hospitals. “We’ve kind of written these communities off as ...
Source: TIME: Health - June 11, 2018 Category: Consumer Health News Authors: TIME Staff Tags: Uncategorized community health workers Dr. Raj Panjabi ebola Health Care Last Mile Health medicine TIME 100 TIME 100 x WeWork Speaker Series Zika Source Type: news

Bill And Melinda Gates Start A Nonprofit Biotech In Boston
The Bill& Melinda Gates Medical Research Institute, which is holding an event today to show off its plans, will aim to develop new medicines and vaccines for malaria, tuberculosis, and diarrhea, which together account for 2.6 million deaths a year globally, many of them in children. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 7, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

Malaria: Cooperating antibodies enhance immune response
In this study, the researchers discovered a previously unnoticed characteristic of antibodies against the malaria parasite: They can cooperate with each other, thus binding even stronger to the pathogens and improving the immune response. The results, now published in Science, are expected to help develop a more effective vaccine against the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 7, 2018 Category: Infectious Diseases Source Type: news

Rwanda:Hygiene is the Primary Vaccine Against Child Disease - Minister Gashumba
[New Times] The Minister for Health, Dr Diane Gashumba, has urged members of the public to uphold hygiene, starting from the household, in a bid to fight malaria and other poor hygiene-induced diseases. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 17, 2018 Category: African Health Source Type: news

Major enhancement to in vitro testing of human liver-stage malaria
(University of South Florida (USF Health)) Researchers have developed an enhanced method to conducting liver-stage malaria research in vitro, allowing them to more quickly screen preclinical drugs and vaccines than current techniques. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2018 Category: International Medicine & Public Health Source Type: news

How Imams, Royalty and Family Celebrations are Wiping Out Polio in Nigeria
Ramlatu Musaa never met the Emir of Kano State in northern Nigeria. Of course, Ramlatu Musaa hasn’t met a lot of people. She’s only about a week old, born in Kano on April 29, 2018, and yet in some ways, the Emir may have helped saved her life. Two years ago, the polio vaccine was available in Nigeria, but it was still frequently rejected by families. Stray rumors continued to circulate that it was unsafe, able to sicken children and render them infertile. So before one of that year’s national vaccination campaigns began, the Emir—a hereditary leader descended from a ruling family—appeared at ...
Source: TIME: Health - May 7, 2018 Category: Consumer Health News Authors: Jeffrey Kluger / Kano Tags: Uncategorized healthytime public health Source Type: news

How Imams, Royalty and Family Celebrations are Wiping Out Polio in Nigeria
Ramlatu Musaa never met the Emir of Kano State in northern Nigeria. Of course, Ramlatu Musaa hasn’t met a lot of people. She’s only about a week old, born in Kano on April 29, 2018, and yet in some ways, the Emir may have helped saved her life. Two years ago, the polio vaccine was available in Nigeria, but it was still frequently rejected by families. Stray rumors continued to circulate that it was unsafe, able to sicken children and render them infertile. So before one of that year’s national vaccination campaigns began, the Emir—a hereditary leader descended from a ruling family—appeared at ...
Source: TIME: Science - May 7, 2018 Category: Science Authors: Jeffrey Kluger / Kano Tags: Uncategorized healthytime public health Source Type: news